Additionally, FoxQ1 might be associated with resistance to conventional chemotherapy and downregulation of FoxQ1 may increase the sensitivity of chemotherapeutic reagents, with important implications in cancer progression and treatment. This evidence concerns the gene FOXQ1 and cancer.